The Abbott FlexAbility™ ablation catheter | 合法醫療器材資訊網

Abbott announces FDA approval of FlexAbilityTM Ablation Catheter, Sensor EnabledTM to advance the treatment of complex cardiac arrhythmias

- Sensor EnabledTM tool complements the EnSite PrecisionTM cardiac mapping system and expands Abbotts comprehensive advanced cardiac mapping and ablation portfolio

ABBOTT PARK, Ill., March 1, 2017 — Abbott today announced U.S. Food and Drug Administration (FDA) approval of the FlexAbility™ Ablation Catheter, Sensor Enabled™[1] designed to improve the versatility and precision during cardiac ablation procedures to treat atrial flutter, a type of irregular heartbeat. With the approval, the company has further expanded its electrophysiology portfolio for treating patients struggling with abnormal heart rhythms (cardiac arrhythmias).

The FlexAbility™ Ablation Catheter, Sensor Enabled™ is the first ablation catheter from Abbott that helps collect bot...